11,122$
-1,75%
Echtzeit-Aktienkurs Viatris Inc.
Bid:
Ask:
Echtzeit-Chart der Viatris Inc. Aktie
Börsenkurse Viatris Inc.
| Börse Frankfurt | - | - | - | - | 10,475€ | -1,41% |
| Börse Stuttgart | - | - | - | - | 10,465€ | -1,46% |
| Nasdaq | - | - | - | - | 11,110$ | -1,86% |
| Echtzeit Euro | - | - | - | - | 10,463€ | -2,86% |
| Xetra | - | - | - | - | 10,520€ | -2,32% |
| Echtzeit USD | - | - | - | - | 11,122$ | -1,75% |
| Tradegate | - | - | - | - | 10,465€ | -1,64% |
| gettex | - | - | - | - | 10,470€ | -1,81% |
| Lang & Schwarz | - | - | - | - | 10,500€ | -1,50% |
Fundamentaldaten der Viatris Inc. Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [USD] | 15,38 Mrd. | 202,90 Mio. | 54,70 Mio. | 0,05 | 4,32% | 247,15 | 0,87 |
| 2022 [USD] | 16,17 Mrd. | 2,81 Mrd. | 2,08 Mrd. | 1,71 | 4,32% | 6,52 | 0,83 |
| 2021 [USD] | 17,86 Mrd. | -664,40 Mio. | -1,27 Mrd. | -1,05 | 2,97% | - | 0,75 |
| 2020 [USD] | 11,94 Mrd. | -721,20 Mio. | -669,90 Mio. | -1,11 | - | - | 1,12 |
| 2019 [USD] | 11,50 Mrd. | 154,40 Mio. | 16,80 Mio. | 0,03 | - | 347,56 | 0,50 |
| 2018 [USD] | 11,43 Mrd. | 298,40 Mio. | 352,50 Mio. | 0,68 | - | 16,31 | 0,50 |
| 2017 [USD] | 11,91 Mrd. | 903,00 Mio. | 696,00 Mio. | 1,30 | - | 8,56 | 0,49 |
| 2016 [USD] | 11,12 Mrd. | 121,70 Mio. | 480,00 Mio. | 0,92 | - | 12,09 | 0,54 |
| 2015 [USD] | 9,47 Mrd. | 915,40 Mio. | 847,60 Mio. | 1,70 | - | 6,54 | 0,58 |
| 2014 [USD] | 7,77 Mrd. | 974,50 Mio. | 929,40 Mio. | 2,34 | - | 4,75 | 0,54 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Viatris Inc. Aktie
Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.